Brief: Zentalis Pharmaceuticals Reports Full Year 2022 Financial Results And Operational Updates
Zentalis Pharmaceuticals Inc ZNTL.O :
* ZENTALIS PHARMACEUTICALS REPORTS FULL YEAR 2022 FINANCIAL
RESULTS AND OPERATIONAL UPDATES
* $437 MILLION CASH BALANCE AS OF DECEMBER 31, 2022, WITH
PROJECTED CASH RUNWAY INTO Q2 2025
Source text for Eikon: ID:nGNX2x8XJ2
Further company coverage: ZNTL.O
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer